An AI-powered platform for healthcare publishers to reclaim control, deepen HCP engagement, and unlock new revenue streams in the AI era.
Let's TalkWhere Healthcare Publishers Stand Today
Three structural shifts are reshaping the publishing landscape.
Impressions, subscriptions, and engagement metrics are under pressure.
AI now answers healthcare questions before users reach publisher sites.
Medical content is being scraped, repurposed, and monetized without publisher consent.
What Publishers Get with Publisher AI Suite
New monetization streams through content licensing and premium AI inventory.
Deeper HCP interactions through personalized AI experiences that keep users on your domain.
Verified content licensing, bot protection, and direct monetization of your IP.
Site LLM
The Engagement Engine
A private AI assistant trained exclusively on your verified medical content—running within your site ecosystem with built-in compliance.
- Personalization by specialty, region, learning behavior
- Interactive chat + summaries that keep HCPs on-site longer
- Medically accurate, audit-ready, regulatory compliant
AI Ads
Premium Inventory
Monetize the "AI Chat Screen" without breaking the experience.
- Contextual Display: Premium placements alongside chat
- Native AI Text: Keyword-triggered sponsor messages in responses
- Sponsored Recommendations: Sponsor CME/education suggestions
- Industry’s 1ˢᵗ Virtual Brand Rep: Video/voice/chat brand rep in-chat
Licensed Content Marketplace
New Revenue From Verified Content Licensing
Control and monetize content directly—license to pre-vetted buyers with transparent, tokenized contracts.
- Content onboarding (articles, abstracts, datasets, images, CME modules)
- Verification & compliance for every buyer and use case
- Smart contracts with usage rights, time limits, attribution
- Revenue tracking dashboards for royalties + usage metrics
Measurable Outcomes Across Key Metrics
Extended Session Duration
HCPs stay longer on your site with AI-powered experiences, increasing impressions and conversions.
New AI Advertising Revenue
AI conversations create premium inventory through contextual display, native text, sponsored recommendations, and virtual brand rep.
Recurring Content Licensing Income
Transform scraped content into a licensable asset generating recurring revenue from AI companies, pharma, and CME providers.
Content Visibility & Attribution
Track exactly who licenses your content, how it's used, and receive proper attribution.
Intelligent Content Protection
Behavioral bot detection reduces unauthorized scraping while allowing legitimate search engine crawlers.
Extended Session Duration
HCPs stay longer on your site with AI-powered experiences, increasing impressions and conversions.
New AI Advertising Revenue
AI conversations create premium inventory through contextual display, native text, sponsored recommendations, and virtual brand rep.
Recurring Content Licensing Income
Transform scraped content into a licensable asset generating recurring revenue from AI companies, pharma, and CME providers.
Content Visibility & Attribution
Track exactly who licenses your content, how it's used, and receive proper attribution.
Intelligent Content Protection
Behavioral bot detection reduces unauthorized scraping while allowing legitimate search engine crawlers.

Ready to enhance ad monetization and achieve superior engagement for your publication?
Schedule a DemoCustomer Testimonials
“We like the fact that Doceree offers omni-channel orchestration and automation. We know that Doceree, unlike other aggregators, offers direct and fully integrated platform technology that enables faster & more granular reporting.”
“Doceree's strength lies in its ability to have an all- encompassing inventory and be an aggregator of diverse platforms. I also think Doceree's reporting capabilities are a real strength.”
“Doceree can track back-listed prescriptions from the media. Doceree's dashboard is also very helpful. The dashboard provides insight into an ongoing campaign's performance and streamlines our analytical workflow.”



